Previous Page  4 / 18 Next Page
Information
Show Menu
Previous Page 4 / 18 Next Page
Page Background

Volume 4, Issue 7(Suppl)

J Infect Dis Ther 2016

ISSN: 2332-0877, JIDT an open access journal

Page 49

Notes:

Skin Diseases & Microbiology 2016

October 03-05, 2016

conferenceseries

.com

October 03-05, 2016 Vancouver, Canada

International Conference on

Infectious Diseases, Diagnostic Microbiology &

Dermatologists Summit on Skin Infections

In silico

design of a hexavalent protein, a potential candidate vaccine against

Staphylococcus aureus

biofilm-related infection

Maryam Shahbazi

Shiraz University, Iran

S

taphylococcus aureus

possessing a pool of virulence factors is responsible for the significant and increasing number of hospital and

community-acquired infections worldwide. Developing a potential vaccine to prevent these life-threatening and drug-resistant

infections would have many advantageous impacts on global healthiness. In this study, considering the biofilm mode of growth and

polymicrobial nature of

S. aureus

and

Candida albicans

co-infections, a multivalent protein vaccine was designed. In the first phase,

the prediction of putative antigenic targets of

S. aureus

and

C. albicans

was conducted based on data mining and bioinformatic

characterization of their proteins. Various properties of the proteins were evaluated such as subcellular localization, hydrophilicity,

repeat containing modules, beta turns, surface accessibility and number of antigenic determinants. Eventually, 6 proteins AlS, ClfA,

FtmB, SdrE, Spa and Bap were selected. The second phase included various immunoinformatics analyses on their sequences leading

to design of a novel sub-unit hexavalent candidate vaccine. Several potential T cell and B cell epitopes are present in this synthetic

construct and it is expected to strongly induce IFN-gamma production. In conclusion, the amino acid sequence introduced here is

expected to enhance T cell-mediated and humoral responses against

S. aureus

biofilm-related infections to clear biofilm communities

of

S. aureus

and intracellular colonies of pathogen as well as planktonic cells and thus reducing colonization and persistence.

Biography

Maryam Shahbazi has completed her PhD program in Bacteriology from Shiraz University in 2016 with the thesis entitled “Design and Synthesis of a Protein Candidate

Vaccine against

S. aureus

Biofilm Related Infections”. She is a Researcher and has published 6 articles in peer reviewed journals.

shahbazimaryam70@yahoo.com

Maryam Shahbazi, J Infect Dis Ther 2016, 4:7(Suppl)

http://dx.doi.org/10.4172/2332-0877.C1.018